MGO One Seven’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31M Sell
122,187
-11,091
-8% -$2.58M 0.51% 31
2026
Q1
$32.6M Buy
133,278
+1,991
+2% +$464K 0.65% 22
2025
Q4
$27.2M Buy
131,287
+5,280
+4% +$1.04M 0.55% 28
2025
Q3
$23.4M Buy
126,007
+44,269
+54% +$7.58M 0.54% 27
2025
Q2
$12.5M Buy
81,738
+847
+1% +$130K 0.4% 46
2025
Q1
$13.4M Buy
80,891
+4,449
+6% +$696K 0.52% 33
2024
Q4
$11.1M Buy
76,442
+7,454
+11% +$1.16M 0.42% 42
2024
Q3
$11.2M Buy
68,988
+18,233
+36% +$2.9M 0.48% 36
2024
Q2
$7.42M Sell
50,755
-3,474
-6% -$517K 0.35% 64
2024
Q1
$8.58M Sell
54,229
-1,439
-3% -$229K 0.45% 46
2023
Q4
$8.73M Buy
55,668
+10,682
+24% +$1.64M 0.5% 38
2023
Q3
$7.01M Sell
44,986
-15,096
-25% -$2.49M 0.54% 37
2023
Q2
$9.94M Sell
60,082
-3,200
-5% -$516K 0.91% 14
2023
Q1
$9.81M Buy
63,282
+2,653
+4% +$428K 0.62% 25
2022
Q4
$10.7M Buy
60,629
+2,793
+5% +$482K 1.07% 13
2022
Q3
$19.3K Buy
57,836
+2,446
+4% +$414K 0.75% 23
2022
Q2
$9.83M Sell
55,390
-665
-1% -$118K 1.36% 7
2022
Q1
$9.94M Sell
56,055
-143
-0.3% -$24.3K 1.07% 8
2021
Q4
$9.61M Buy
56,198
+21,337
+61% +$3.49M 1% 10
2021
Q3
$5.68M Buy
34,861
+146
+0.4% +$24.9K 0.72% 22
2021
Q2
$5.72M Buy
34,715
+1,925
+6% +$319K 0.8% 18
2021
Q1
$5.39M Buy
32,790
+1,084
+3% +$175K 0.93% 12
2020
Q4
$4.99M Sell
31,706
-360
-1% -$53.1K 1.03% 10
2020
Q3
$4.77M Sell
32,066
-542
-2% -$80.2K 1.13% 8
2020
Q2
$4.59M Buy
32,608
+1,839
+6% +$268K 1.19% 7
2020
Q1
$4.03M Buy
30,769
+929
+3% +$132K 1.37% 6
2019
Q4
$4.35M Sell
29,840
-572
-2% -$77.6K 1.14% 11
2019
Q3
$3.94M Buy
30,412
+7,622
+33% +$1M 1.13% 11
2019
Q2
$3.17M Buy
22,790
+3,536
+18% +$489K 1.02% 14
2019
Q1
$2.69M Buy
19,254
+4,810
+33% +$644K 0.88% 14
2018
Q4
$1.86M Buy
14,444
+1,279
+10% +$178K 0.8% 16
2018
Q3
$1.82M Buy
+13,165
New +$1.75M 0.85% 18
2018
Q1
$1.4M Sell
10,920
-96
-0.9% -$13K 0.64% 19
2017
Q4
$1.54M Buy
+11,016
New +$1.53M 0.71% 15

Other funds holding JNJ

MGO One Seven's JNJ Position: Q2 2026 in Review

MGO One Seven reduced its Johnson & Johnson (JNJ) stake by 8.3% in Q2 2026, selling an estimated $2.58M and leaving 122,187 shares worth $31M. The position accounts for 0.51% of the portfolio, ranked #31.

MGO One Seven first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. The position peaked at $32.6M in Q1 2026. 3,608 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • MGO One Seven held 122,187 shares of Johnson & Johnson worth $31M as of Q2 2026.
  • MGO One Seven sold 11,091 Johnson & Johnson shares in Q2 2026, an estimated $2.58M.
  • Johnson & Johnson made up 0.51% of MGO One Seven's portfolio in Q2 2026, its #31 holding.
  • MGO One Seven first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
  • MGO One Seven's Johnson & Johnson position peaked at $32.6M in Q1 2026.
  • 3,608 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.